Pharmaceutical preparation exhibiting pharmacological activity as kappa-opiate agonist
Pou it N-methyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-difenylacetamidhydrochloridu pro v²robu farmaceutick ho prost°edku s farmakologick²m p soben m jako to kappa-opi tov² agonista pro o et°ov n z n tliv²ch st°evn ch onemocn n .\ In the present invention there is disclosed the...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | cze ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Pou it N-methyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-difenylacetamidhydrochloridu pro v²robu farmaceutick ho prost°edku s farmakologick²m p soben m jako to kappa-opi tov² agonista pro o et°ov n z n tliv²ch st°evn ch onemocn n .\
In the present invention there is disclosed the use of N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamidohydrochloride for preparing a pharmaceutical preparation exhibiting pharmacological activity as kappa-opiate agonist and intended for treating inflammatory intestinal diseases. |
|---|